KR20150091170A - 프로스타사이클린 유사체의 합성 방법 - Google Patents

프로스타사이클린 유사체의 합성 방법 Download PDF

Info

Publication number
KR20150091170A
KR20150091170A KR1020157018095A KR20157018095A KR20150091170A KR 20150091170 A KR20150091170 A KR 20150091170A KR 1020157018095 A KR1020157018095 A KR 1020157018095A KR 20157018095 A KR20157018095 A KR 20157018095A KR 20150091170 A KR20150091170 A KR 20150091170A
Authority
KR
South Korea
Prior art keywords
formula
compound
produce
reacting
organic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020157018095A
Other languages
English (en)
Korean (ko)
Inventor
커크 윌리엄 헤링
질 챔부르니어
그레고리 윌리엄 엔드레스
빅토르 페디
토마스 제임스 2세 크렐
후세인 마흐무드 마흐무드
Original Assignee
카이맨 케미칼 컴파니 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카이맨 케미칼 컴파니 인코포레이티드 filed Critical 카이맨 케미칼 컴파니 인코포레이티드
Publication of KR20150091170A publication Critical patent/KR20150091170A/ko
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/34Separation; Purification; Stabilisation; Use of additives
    • C07C41/44Separation; Purification; Stabilisation; Use of additives by treatments giving rise to a chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/235Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/253Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/32Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1852
    • C07F7/1856
    • C07C2103/14
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/14Benz[f]indenes; Hydrogenated benz[f]indenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1020157018095A 2012-12-07 2013-12-06 프로스타사이클린 유사체의 합성 방법 Ceased KR20150091170A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261734672P 2012-12-07 2012-12-07
US61/734,672 2012-12-07
US201361777882P 2013-03-12 2013-03-12
US61/777,882 2013-03-12
PCT/US2013/073474 WO2014089385A2 (en) 2012-12-07 2013-12-06 Methods of synthesizing a prostacyclin analog

Publications (1)

Publication Number Publication Date
KR20150091170A true KR20150091170A (ko) 2015-08-07

Family

ID=49881039

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157018095A Ceased KR20150091170A (ko) 2012-12-07 2013-12-06 프로스타사이클린 유사체의 합성 방법

Country Status (20)

Country Link
US (4) US20150315114A1 (enExample)
EP (2) EP2928858B1 (enExample)
JP (2) JP6342414B2 (enExample)
KR (1) KR20150091170A (enExample)
CN (3) CN110590547A (enExample)
AU (2) AU2013355130B2 (enExample)
BR (1) BR112015013085A2 (enExample)
CA (1) CA2893604A1 (enExample)
CL (1) CL2015001535A1 (enExample)
DK (1) DK2928858T3 (enExample)
EA (1) EA034309B1 (enExample)
ES (1) ES2664026T3 (enExample)
IL (1) IL239172B (enExample)
MX (2) MX369094B (enExample)
NZ (1) NZ708130A (enExample)
PE (1) PE20160090A1 (enExample)
PH (2) PH12015501258A1 (enExample)
SG (2) SG10201600303WA (enExample)
TW (1) TWI634104B (enExample)
WO (1) WO2014089385A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220030006A (ko) 2020-09-02 2022-03-10 바이오플러스 주식회사 미용 조성물을 포함하는 마스크 및 그 제조 방법

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20160090A1 (es) * 2012-12-07 2016-02-20 Cayman Chemical Co Inc Metodos para sintetizar un analogo de la prostaciclina
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
US9371264B2 (en) 2013-01-11 2016-06-21 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
WO2015073314A1 (en) * 2013-11-13 2015-05-21 Cayman Chemical Company Incorporated Amine salts of a prostacyclin analog
HU231186B1 (hu) 2014-10-08 2021-06-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás treprostinil és sói előállítására
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
EP3515430A1 (en) 2016-09-26 2019-07-31 United Therapeutics Corporation Treprostinil prodrugs
EP3498283A1 (en) 2017-12-14 2019-06-19 Ipsol AG Glycosidic derivatives of treprostinil
HU231296B1 (hu) * 2018-03-09 2022-09-28 Chinoin Zrt Eljárás treprostinil-dietanol-amin só B polimorf formájának előállítására
JP6503508B2 (ja) * 2018-08-03 2019-04-17 Jxtgエネルギー株式会社 テトラカルボン酸二無水物、ポリイミド前駆体樹脂、ポリイミド、ポリイミド前駆体樹脂溶液、ポリイミド溶液及びポリイミドフィルム
JP2022546314A (ja) 2019-08-23 2022-11-04 ユナイテッド セラピューティクス コーポレイション トレプロスチニルプロドラッグ
US11826327B2 (en) 2020-04-17 2023-11-28 United Therapeutics Corporation Treatment for interstitial lung disease
KR20250057075A (ko) 2020-06-09 2025-04-28 유나이티드 쎄러퓨틱스 코포레이션 트레프로스티닐의 푸마릴 디케토피페리딘 프로드러그
JP7826317B2 (ja) 2020-12-14 2026-03-09 ユナイテッド セラピューティクス コーポレイション トレプロスチニルプロドラッグで疾患を治療する方法
EP4301372A1 (en) 2021-03-03 2024-01-10 United Therapeutics Corporation A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp)
US11884640B2 (en) * 2021-06-02 2024-01-30 Chirogate International Inc. Processes and intermediates for the preparations of benzoprostacyclin analogues and benzoprostacyclin analogues prepared therefrom
US11884613B2 (en) * 2022-05-05 2024-01-30 Chirogate International Inc. Processes and intermediates for the preparation of carbaprostacyclin analogues

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
CA2039857A1 (en) * 1990-04-26 1991-10-27 Wilfred Po-Sum Shum Process for producing epoxyalcohols of high optical purity
US6441245B1 (en) 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
WO2005007081A2 (en) * 2003-05-22 2005-01-27 United Therapeutics Corporation Compounds and methods for delivery of prostacyclin analogs
US8293715B2 (en) * 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
EP2252570B1 (en) 2007-12-17 2017-04-05 United Therapeutics Corporation An improved process to prepare treprostinil, the active ingredient in remodulin ®
WO2009158010A1 (en) * 2008-06-27 2009-12-30 Concert Pharmaceuticals, Inc. Prostacyclin analogs
WO2010039531A1 (en) * 2008-09-23 2010-04-08 Resolvyx Pharmaceuticals, Inc. Therapeutic compounds
CN101891596B (zh) * 2009-05-22 2013-12-11 上海天伟生物制药有限公司 一种化合物及其制备方法和用途
EP2576492B1 (en) * 2010-06-03 2017-09-20 United Therapeutics Corporation Treprostinil production
CA2710726C (en) * 2010-07-22 2016-02-23 Alphora Research Inc. Synthesis of treprostinil and intermediates useful therein
CN103238070B (zh) 2010-10-01 2016-06-29 丹麦国家医院 能够调节/保护内皮完整性的用于预防或治疗急性创伤性凝血病和心脏骤停复苏的化合物
US8865898B2 (en) * 2010-11-30 2014-10-21 Japan Science And Technology Agency Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
US8524939B2 (en) 2011-08-24 2013-09-03 Chirogate International Inc. Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
CN102796134B (zh) * 2012-08-31 2015-07-01 甘肃皓天化学科技有限公司 一种马沙骨化醇中间体的制备方法
PE20160090A1 (es) * 2012-12-07 2016-02-20 Cayman Chemical Co Inc Metodos para sintetizar un analogo de la prostaciclina
WO2015073314A1 (en) * 2013-11-13 2015-05-21 Cayman Chemical Company Incorporated Amine salts of a prostacyclin analog

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220030006A (ko) 2020-09-02 2022-03-10 바이오플러스 주식회사 미용 조성물을 포함하는 마스크 및 그 제조 방법

Also Published As

Publication number Publication date
EP2928858A2 (en) 2015-10-14
PH12018500562A1 (en) 2019-03-04
US20150315114A1 (en) 2015-11-05
HK1212323A1 (en) 2016-06-10
US20180141889A1 (en) 2018-05-24
PE20160090A1 (es) 2016-02-20
ES2664026T3 (es) 2018-04-18
US20170297995A1 (en) 2017-10-19
BR112015013085A2 (pt) 2017-07-11
SG11201504430TA (en) 2015-07-30
WO2014089385A2 (en) 2014-06-12
EP2928858B1 (en) 2018-01-31
EP3398931A1 (en) 2018-11-07
DK2928858T3 (en) 2018-02-19
CA2893604A1 (en) 2014-06-12
MX2019009102A (es) 2019-09-16
US20200002261A1 (en) 2020-01-02
CN110590547A (zh) 2019-12-20
PH12015501258B1 (en) 2015-08-17
TWI634104B (zh) 2018-09-01
AU2013355130A1 (en) 2015-06-11
CN107098925B (zh) 2019-09-13
CN104837806A (zh) 2015-08-12
US9908834B2 (en) 2018-03-06
MX369094B (es) 2019-10-29
SG10201600303WA (en) 2016-02-26
IL239172B (en) 2020-01-30
NZ708130A (en) 2020-01-31
CN107098925A (zh) 2017-08-29
AU2018233009B2 (en) 2020-01-23
EP3398931B1 (en) 2020-04-08
JP2016504303A (ja) 2016-02-12
EA034309B1 (ru) 2020-01-27
WO2014089385A3 (en) 2014-08-28
CL2015001535A1 (es) 2016-01-15
IL239172A0 (en) 2015-07-30
MX2015006972A (es) 2016-02-11
AU2013355130B2 (en) 2018-06-21
JP2018162250A (ja) 2018-10-18
PH12015501258A1 (en) 2015-08-17
AU2018233009A1 (en) 2018-10-18
TW201422577A (zh) 2014-06-16
JP6342414B2 (ja) 2018-06-13
US10450257B2 (en) 2019-10-22
EA201591093A1 (ru) 2015-09-30

Similar Documents

Publication Publication Date Title
KR20150091170A (ko) 프로스타사이클린 유사체의 합성 방법
KR20160086837A (ko) 프로스타사이클린 유사체의 아민 염
JP5492786B2 (ja) ゼラレノンマクロライドアナログを作製するための中間体および方法
HK1212323B (en) Methods of synthesizing a prostacyclin analog
FR3025200A1 (fr) Derives de n-aryl-tricyclopyrimidine-2-amine polyethers macrocycliques

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20150706

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20181205

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200427

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20200812

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20200427

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I